Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review

RECOMMENDED

COPD

Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis

Cochrane Database Syst Rev.

Oba Y, Keeney E, Ghatehorde N, Dias S

doi: 10.1002/14651858.

COPD

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD

Pulm Pharmacol Ther.

Mandal J, Roth M, Papakonstantinou E, Sun Q, Costa L, Boeck L, Scherr A, Rakic J, Louis R, Milenkovic B, Boersma W, Kostikas K, Blasi F, Aerts J, Rohde G, Lacoma A, Torres A, Welte T, Tamm M, Stolz D

doi: 10.1016/j.pupt.2017.10.011.

Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery

Mol Clin Oncol.

Makino T, Otsuka H, Hata Y, Koezuka S, Azuma Y, Isobe K, Sugino K, Ebihara S, Homma S, Iyoda A

doi: 10.3892/mco.2018.1595.

RECOMMENDED

COPD

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β₂-agonist fixed-dose combinations in COPD

Ther Adv Respir Dis.

Siddiqui MK, Shukla P, Jenkins M, Ouwens M, Guranlioglu D, Darken P, Biswas M

doi: 10.1177/1753466619894502.

RECOMMENDED

COPD

Triple therapy versus single and dual long-acting bronchodilator therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Eur Respir J.

Cazzola M, Rogliani P, Calzetta L, Matera MG

doi: 10.1183/13993003.

Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes

Respir Res.

Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, Dekhuijzen R

doi: 10.1186/s12931-017-0710-y.

COMMENTED

Asthma

Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β₂-agonists for adults with asthma

Respir Med.

Buhl R, FitzGerald JM, Busse WW

doi: 10.1016/j.rmed.2018.08.014.

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

Eur Respir Rev.

Busse WW, Dahl R, jenkins C, Cruz AA

doi: 10.1183/

AsthmaCOPD

Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey

Int J Chron Obstruct Pulmon Dis

Ding B, Small M

doi: 10.2147/COPD.S136314.

Related content

Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD

Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPD

Triple therapy versus single and dual long-acting bronchodilator therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes

Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β₂-agonist fixed-dose combinations in COPD

Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β₂-agonists for adults with asthma